论文部分内容阅读
目的探讨吸入激素联合祛痰剂在儿童毛细支气管炎临床治疗中的效果及不良反应。方法收集住院经临床诊断的70例毛细支气管炎患儿,分为观察组和对照组,对照组使用抗病毒、祛痰、平喘等及雾化吸入地塞米松和糜蛋白酶治疗,观察组在抗炎、平喘、抗病毒治疗基础上加用布地奈德联合联合氨溴索吸入治疗,评价两组患者临床症状改善时间等方面效果。结果观察组总有效率达94.1%,明显优于对照组,17例患者达到显效,住院时间明显短于对照组。结论布地奈德及祛痰剂吸入治疗是临床简便易行,效果可靠的缓解毛细支气管炎患儿咳喘症状的方法,能够有效控制患儿咳喘症状,且无明显的激素全身应用副作用。
Objective To investigate the effects and adverse reactions of inhaled corticosteroids combined with expectorants in the treatment of children bronchiolitis. Methods A total of 70 patients with bronchiolitis diagnosed in hospital were collected and divided into observation group and control group. The control group was treated with anti-virus, expectorant, antiasthmatic and inhalation of dexamethasone and chymotrypsin. Anti-inflammatory, antiasthmatic and antiviral therapy plus budesonide combined with ambroxol inhalation therapy, evaluation of two groups of patients with clinical symptoms such as time to improve the effect. Results The total effective rate of the observation group was 94.1%, which was significantly better than that of the control group. Seventeen patients achieved markedly effective and the hospitalization time was significantly shorter than that of the control group. Conclusion The inhalation of budesonide and expectorant is a simple, effective and reliable method for relieving cough and asthma in children with bronchiolitis. It can effectively control the symptoms of cough and asthma in children and has no obvious side effect of systemic application of hormones.